These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1373244)

  • 1. [The expansion of NK CD56+ cells with reduced cytotoxicity in a female patient with systemic sclerosis].
    Famularo G; Quintieri F; D'Ambrosio A; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
    Recenti Prog Med; 1992 Jan; 83(1):18-20. PubMed ID: 1373244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of in vitro immunoglobulin synthesis by CD16(Leu11a)+ CD56 (NKH1,Leu19)+non-T lineage NK cells; lack of suppression of cells from immunodeficient patients.
    Morio T; Nonoyama S; Yata J
    Clin Exp Immunol; 1989 Nov; 78(2):159-65. PubMed ID: 12412742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
    Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
    J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis.
    Grazia Cifone M; Giacomelli R; Famularo G; Paolini R; Danese C; Napolitano T; Procopio A; Perego AM; Santoni A; Tonietti G
    Clin Exp Immunol; 1990 Jun; 80(3):360-5. PubMed ID: 2372985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder].
    Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M
    Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
    Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells and gamma delta T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies.
    Holcombe RF; Baethge BA; Wolf RE; Betzing KW; Stewart RM
    Ann Rheum Dis; 1995 Jan; 54(1):69-72. PubMed ID: 7533490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell frequency and function in patients with monoclonal gammopathies.
    Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
    J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
    Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
    Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
    J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
    Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
    Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
    Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
    Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation.
    De Angelis C; Mancusi A; Ruggeri L; Capanni M; Urbani E; Velardi A; Stern M
    Acta Haematol; 2011; 126(1):13-20. PubMed ID: 21411985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural killer cells of different immunological phenotypes (CD16+, CD56+ and CD57+) in the blood of patients with insulin-dependent diabetes mellitus].
    Shliakhovenko VS; Guzov MA; Milenko SE; Mikhaĭlovskaia EV; Kalinovskiĭ AK; Khodak AA; Zak KP
    Vrach Delo; 1991 Feb; (2):36-9. PubMed ID: 1711735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.